Auralis
Halton
About Auralis
Auralis developed generic pharmaceutical products for niche markets, which were subject to licence or regulatory approval providing barriers to entry to protect margin and revenue.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Funding stage: M&A
- Last round: Seed (Apr 2008)
- Website: auralis.co.uk
Industries & Categories
Biotechnology, Pharmaceutical
Canonical: https://fsome.com/organization/auralis-3132353 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.